ATE278793T1 - Methoden und zusammensetzungen für die expression von heterologen genen in leberzellen unter verwendung von vektoren, die von hepadnaviren abgeleitet sind - Google Patents

Methoden und zusammensetzungen für die expression von heterologen genen in leberzellen unter verwendung von vektoren, die von hepadnaviren abgeleitet sind

Info

Publication number
ATE278793T1
ATE278793T1 AT99946642T AT99946642T ATE278793T1 AT E278793 T1 ATE278793 T1 AT E278793T1 AT 99946642 T AT99946642 T AT 99946642T AT 99946642 T AT99946642 T AT 99946642T AT E278793 T1 ATE278793 T1 AT E278793T1
Authority
AT
Austria
Prior art keywords
methods
hepatocytes
compositions
gene
hepadnavirus
Prior art date
Application number
AT99946642T
Other languages
English (en)
Inventor
Heinz Schaller
Ulrike Protzer
Michael Nassal
Original Assignee
Heinz Schaller
Ulrike Protzer
Michael Nassal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinz Schaller, Ulrike Protzer, Michael Nassal filed Critical Heinz Schaller
Application granted granted Critical
Publication of ATE278793T1 publication Critical patent/ATE278793T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10141—Use of virus, viral particle or viral elements as a vector
    • C12N2730/10143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99946642T 1998-08-26 1999-08-26 Methoden und zusammensetzungen für die expression von heterologen genen in leberzellen unter verwendung von vektoren, die von hepadnaviren abgeleitet sind ATE278793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9817398P 1998-08-26 1998-08-26
PCT/US1999/019452 WO2000012739A1 (en) 1998-08-26 1999-08-26 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors

Publications (1)

Publication Number Publication Date
ATE278793T1 true ATE278793T1 (de) 2004-10-15

Family

ID=22267717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99946642T ATE278793T1 (de) 1998-08-26 1999-08-26 Methoden und zusammensetzungen für die expression von heterologen genen in leberzellen unter verwendung von vektoren, die von hepadnaviren abgeleitet sind

Country Status (5)

Country Link
US (1) US20050009185A1 (de)
EP (1) EP1108050B1 (de)
AT (1) ATE278793T1 (de)
DE (1) DE69920930T2 (de)
WO (1) WO2000012739A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS137602A0 (en) * 2002-03-26 2002-05-09 Melbourne Health Viral packaging system
US7329485B2 (en) * 2005-10-12 2008-02-12 The Board Of Regents Of The University Of Oklahoma Methods for detecting compounds that interfere with protein aggregation utilizing an in vitro fluorescence-based assay
CN111978414A (zh) * 2020-08-28 2020-11-24 江苏农牧科技职业学院 鸭干扰素γ融合蛋白在制备防治鸭病毒性肝炎药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9609932D0 (en) * 1996-05-13 1996-07-17 Hoffmann La Roche Use of IL-12 and IFN alpha for the treatment of infectious diseases
JP2001500376A (ja) * 1996-09-06 2001-01-16 カイロン コーポレイション 組換えａａｖベクターを使用する治療分子の肝臓特異的送達のための方法および組成物
US5981274A (en) * 1996-09-18 1999-11-09 Tyrrell; D. Lorne J. Recombinant hepatitis virus vectors

Also Published As

Publication number Publication date
US20050009185A1 (en) 2005-01-13
WO2000012739A1 (en) 2000-03-09
EP1108050B1 (de) 2004-10-06
DE69920930T2 (de) 2005-10-13
DE69920930D1 (de) 2004-11-11
EP1108050A1 (de) 2001-06-20

Similar Documents

Publication Publication Date Title
Sprinzl et al. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier
Allweiss et al. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection
Lucifora et al. Attacking hepatitis B virus cccDNA–The holy grail to hepatitis B cure
Lenhoff et al. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes
DK1084230T3 (da) Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller
Ma et al. Hepatitis B virus infection and replication in human bone marrow mesenchymal stem cells
CN1365388A (zh) 用于基因转移的病毒包膜载体
Winer et al. Determinants of hepatitis B and delta virus host tropism
JP2002511257A (ja) 目的の遺伝子を発現するための非クローニング技術
WO2019228527A1 (en) Lentiviral vector used for treatment of hemophilia a, lentivirus, and preparation method and application thereof
CN106591228A (zh) 一种同时抵抗细胞衰老及恶性转化的人多能干细胞的制备方法
CN107937442A (zh) 一种永生化人脂肪间充质干细胞系及其建立方法
Hirsch et al. Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA
WO2020149395A1 (ja) 栄養障害型表皮水疱症治療薬
Wang et al. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage
ATE278793T1 (de) Methoden und zusammensetzungen für die expression von heterologen genen in leberzellen unter verwendung von vektoren, die von hepadnaviren abgeleitet sind
CN104726496A (zh) 携带人类成年早衰症基因突变的多能干细胞及制备方法
Fourel et al. Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing
Nakamura et al. Establishment of immortal normal and ataxia telangiectasia fibroblast cell lines by introduction of the hTERT gene
Hu et al. Nonviral gene targeting at rDNA locus of human mesenchymal stem cells
Chng et al. Specific adeno‐associated virus serotypes facilitate efficient gene transfer into human and non‐human primate mesenchymal stromal cells
Sharma et al. Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review
Min et al. Prolonged gene expression in primary porcine pancreatic cells using an Epstein–Barr virus-based episomal vector
FR2600079B1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
Krause et al. Safety of viral DNA in biological products

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1108050

Country of ref document: EP